Real-life effectiveness of budesonide/formoterol for the management of asthma and COPD

Hicham Benhaddi (Brussels, Belgium), Hicham Benhaddi, Marianka Van Der Tol, David Price, Bakhtiyor Khalikulov, Rinat Ariely

Source: International Congress 2016 – Clinical characteristics of asthma
Session: Clinical characteristics of asthma
Session type: Thematic Poster
Number: 627
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Hicham Benhaddi (Brussels, Belgium), Hicham Benhaddi, Marianka Van Der Tol, David Price, Bakhtiyor Khalikulov, Rinat Ariely. Real-life effectiveness of budesonide/formoterol for the management of asthma and COPD. Eur Respir J 2016; 48: Suppl. 60, 627

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cost effectiveness of budesonide/formoterol vs fluticasone/salmeterol: Real-world effectiveness and safety in COPD
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013

Real-life evaluation of budesonide/formoterol (DuoResp Spiromax) for the management of asthma and COPD in the UK
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017


Inhalation technique education and its impact in asthma and COPD
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015

Inhaler competence and patient satisfaction with a DPI; results of two real-life studies in asthma and COPD
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013

Predictors of good inhaler technique in asthma and COPD
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015


Efficacy of budesonide/formoterol maintenance and reliever therapy in mild asthma
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013

Impact of inhaler technique on patient outcomes in asthma patients using diskus in primary care
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014

Comparing pharmacist time use for asthma and COPD patients using various types of inhaler devices
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015


Telehealthcare in COPD – A feasibility trial
Source: International Congress 2016 – Non-inflammatory assessment of airway disorders
Year: 2016


The parameters that may affect inhalation therapy success in elderly COPD and asthma patients
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015


The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016


1-year efficacy and safety study of tiotropium respimat add-on to ICS in adolescent patients with symptomatic asthma
Source: International Congress 2014 – Bronchodilators for asthma and COPD
Year: 2014



Comparable effectiveness of budesonide/formoterol combination and fluticasone for the treatment of cough variant asthma
Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Year: 2013


Difference between asthma and COPD patients in adherence and non-adherence patterns to inhaler devices
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015


Do correct steps using pMDI technique with spacer predict no exacerbations of Asthma or COPD?
Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality
Year: 2016


Importance of inhalation device in asthma and COPD: A consensus using Delphi
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013


Exacerbator subtypes in the tiotropium safety and performance in respimat (TIOSPIR™) trial
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


The budesonide/formoterol inhaler as maintenance and reliever therapy in Maori asthmatics
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013

Safety of once-daily glycopyrronium in patients with severe-to-very severe COPD: The SPARK study
Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Year: 2013


Tiotropium Respimat® add-on therapy in children with symptomatic asthma
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015